Involving Urea Or Urease Patents (Class 435/12)
-
Publication number: 20100047833Abstract: The present invention relates to a diagnostic method for the determination of Helicobacter pylori in a tissue biopsy comprising the step of incubating a tissue biopsy with an aqueous diagnostic reagent comprising urea and a pH indicator, and determining any pH change, characterised in that said diagnostic reagent comprises a lactone, and that the ratio between the volume of the reagent and the volume of the sample is variable and less than 30.Type: ApplicationFiled: March 7, 2008Publication date: February 25, 2010Inventor: Paolo Giordano
-
Patent number: 7662637Abstract: Methods and apparatus (FIG. 4a) are disclosed for selective and very sensitive detection of certain hydrolyzable compounds, especially urea, in water by hydrolyzing said hydrolyzable compounds in a sample of the water to one or more carbon dioxide group compounds and determining the difference in the carbon dioxide content of the water and the hydrolyzed sample using conductivity measurements or other carbon dioxide detector outputs.Type: GrantFiled: December 2, 2002Date of Patent: February 16, 2010Assignee: GE Analytical InstrumentsInventor: Richard D. Godec
-
Patent number: 7595199Abstract: The present invention relates to methods of detecting the presence of detergent- or urea-insoluble amyloid-like fibrils or protein aggregates on filters. Preferably, said fibrils or aggregates are indicative of a disease, preferably of a neurodegenerative disease such as Alzheimer's disease or Huntington's disease. In addition, the present invention relates to inhibitors identified by the method of the invention, to pharmaceutical compositions comprising said inhibitors and to diagnostic compositions useful for the investigation of said amyloid-like fibrils or aggregates.Type: GrantFiled: July 31, 1998Date of Patent: September 29, 2009Assignee: Max-Planck-Gesellschaft zur Förderung der Wissenchaften e.V.Inventors: Erich Wanker, Hans Lehrach, Eberhard Scherzinger, Gillian Bates
-
Patent number: 7582485Abstract: The invention provides a breath testing device which visually indicates the presence of ammonia in a patient's breath, in particular ammonia from helicobacter pylori urease infection. The breath testing device comprises a visual indicating agent which changes color in response to ammonia odors, such as 4,4?-bis(dimethylamino)-benzhydrol (Michler's hydrol or BDMB), pararosaniline base and alpha-naphtholbenzein. The indicating agent is applied to a substrate which is then inserted into a tube or straw, which can be attached to the inlet of a breath collection balloon. When the patient blows into the tube or straw, the indicating agent will change color if it detects levels of ammonia which are consistent with helicobacter pylori urease infection.Type: GrantFiled: October 16, 2003Date of Patent: September 1, 2009Assignee: Kimberly-Clark Worldride, Inc.Inventors: RameshBabu Boga, John Gavin MacDonald
-
Publication number: 20090181412Abstract: Provided is a method of storing a reagent in a microfluidic device. The reagent, in a liquid form, is loaded into reaction chambers arranged on the microfluidic device; followed by lyophilization as being contained in the microfluidic device.Type: ApplicationFiled: December 11, 2008Publication date: July 16, 2009Applicant: SAMSUNG ELECTRONICS CO., LTD.Inventors: Yoon-kyoung CHO, Hee-Kyun LIM, Jeong-gun LEE, Ki-eun KIM, Sung-ho LEE, Chae-joon LEE
-
Publication number: 20090170140Abstract: A BUN (blood urea nitrogen) sensor containing immobilized carbonic anhydrase and immobilized urease for the in vitro detection of urea nitrogen in blood and biological samples with improved performance and precision characteristics.Type: ApplicationFiled: February 25, 2009Publication date: July 2, 2009Applicant: ABBOTT POINT OF CARE INC.Inventors: G. Bruce Collier, Eric Brouwer, Anjulia Wong
-
Publication number: 20090162879Abstract: A measuring device (100a) includes a base body (101) constituting: a sample holding portion (102) configured to hold a test sample containing urea and a material to be detected; and a sample supply port (103) through which the test sample is supplied to the sample holding portion (102). The base body includes an optical measuring portion and a reagent holding portion (111) which are configured to carry out an optical measurement of the test sample held by the sample holding portion (102). The reagent holding portion holds an antibody to the material to be detected and urease which causes hydrolysis of the urea. With this, the present invention provides a measuring device, a measuring apparatus, and a measuring method, each having a simple configuration and capable of reducing measurement errors caused by the urea contained in the test sample and accurately measuring the material to be detected.Type: ApplicationFiled: February 20, 2009Publication date: June 25, 2009Applicant: PANASONIC CORPORATIONInventors: Takahiro Nakaminami, Jin Muraoka
-
Publication number: 20090143487Abstract: This invention is directed to the application of a previously unknown property of nanomaterials—its ability to enhance protein activity and stability at high temperatures, in organic solvents, and in polymer composites. Nanomaterials such as single-walled carbon nanotubes (SWNTs) can significantly enhance enzyme function and stability in strongly denaturing environments. Experimental results and theoretical analysis reveal that the enhancement in stability is a result of the curvature of these nanoscale materials, which suppresses unfavorable protein-protein interactions. The enhanced stability is also exploited in the preparation of highly stable and active nanocomposite films that resist nonspecific protein absorption, i.e., inhibit fouling of the films. The protein-nanoparticles conjugates represent a new generation of highly selective, active, and stable catalytic materials.Type: ApplicationFiled: September 7, 2005Publication date: June 4, 2009Inventors: Jonathan S. Dordick, Ravindra S. Kane, Prashanth Asuri, Sandeep S. Karajanagi
-
Patent number: 7540948Abstract: A BUN (blood urea nitrogen) sensor containing immobilized carbonic anhydrase and immobilized urease for the in vitro detection of urea nitrogen in blood and biological samples with improved performance and precision characteristics.Type: GrantFiled: September 1, 2005Date of Patent: June 2, 2009Assignee: Abbott Point of Care Inc.Inventors: G. Bruce Collier, Eric Brouwer, Anjulia Wong
-
Publication number: 20090098157Abstract: A sterile immunogenic preparation of three purified H. pylori antigens (CagA, VacA and NAP) adjuvanted with alum in an isotonic buffer solution for intramuscular injection. The antigens may be administered in conjunction with antibiotics and/or antisecretories. Urease breath testing, stool antigen testing, and/or immunological analysis may be used as correlate(s) of protection against H. pylori infection. Urea may be used to improve VacA solubility.Type: ApplicationFiled: September 19, 2008Publication date: April 16, 2009Applicant: Novartis Vaccines and Diagnostics s.r.I.Inventor: Giuseppe Del Giudice
-
Patent number: 7485855Abstract: A system and method for cleanup of biological samples from contaminants prior to spectroscopy analysis. The system includes a support configured to hold a sample including a liquid having at least one group of biological molecules with a surface of the support binding the molecules at a surface tension angle to the liquid of less than 180 degrees. The system includes an evaporator configured to evaporate liquid from the support, a solvent applicator configured to apply a solvent for dissolution of the contaminants in the sample, and a solvent removal device configured to remove applied solvent from the sample and thereby at least partially remove the contaminants.Type: GrantFiled: May 26, 2006Date of Patent: February 3, 2009Assignee: Science and Engineering Services, Inc.Inventors: Appavu K. Sundaram, Nelli I. Taranenko, Vladimir M. Doroshenko
-
Patent number: 7476551Abstract: The present invention provides a method of determining whether an individual is at risk for atherosclerosis, comprising the step of: measuring the level of carbamylated LDL in a sample obtained from said individual. Further provided is a method of reducing carbamylation in an individual in need of such reducing, comprising the step of: treating said individual with a monomeric amino acid or another enzymatic or non-enzymatic inhibitor of carbamylation. Also provided is a method of preventing carbamylation in an individual with normal renal function, comprising the step of: treating said individual with a monomeric amino acid. Further provided is a method of treating or preventing atherosclerosis in an individual in need of such reducing, comprising the step of: inhibiting aggregation and/or deposition of carbamylated LDL in said individual.Type: GrantFiled: August 27, 2002Date of Patent: January 13, 2009Assignee: The Board of Trustees of the University of ArkansasInventors: Yousri M. Barri, Sudhir V. Shah, Alexei G. Basnakian
-
Patent number: 7445908Abstract: A method of detecting oxidants in a biological sample comprising: adding a source of ferrous ions to said sample, whereby the presence of oxidants in said sample oxidize at least a portion of said ferrous ions to ferric ions; adding a chromogenic compound to said sample, whereby said chromogenic compound reacts with at least a portion of any ferric ions present in said sample; and detecting for the product of said chromogenic compound-ferric ion reaction; whereby the detection of said chromogenic compound-ferric ion reaction product indicates the presence of oxidants in said sample. The method of detecting adulteration of a urine sample also comprises adding a source of ferrous ions to a urine sample; adding a chromogenic compound to said urine sample; detecting the presence or absence of a chromogenic reaction product; determining a concentration of said chromogenic reaction product; and determining if said concentration signifies adulteration of said urine sample.Type: GrantFiled: April 20, 2004Date of Patent: November 4, 2008Assignee: The United States of America as represented by the Secretary of the ArmyInventor: Buddha D. Paul
-
Publication number: 20080213808Abstract: Embodiments of a detection reagent, as well as test elements and analytical kits including such reagent, and methods for using such reagent, are disclosed herein for optical detection and/or measurement of an analyte in a fluid sample.Type: ApplicationFiled: February 27, 2008Publication date: September 4, 2008Inventor: Wolfgang-Reinhold Knappe
-
Patent number: 7358062Abstract: The press device for a paper web, such as a calender, contains a flexible moving element (1a) forming an endless structure, said element forming the shell (1) of a roll, the press device including further a counter roll. Inside the moving element (1a) there is a shoe element (3) that is arranged to support the shell (1a) against the counter roll to form a nip (N). The width and/or the surface contour of the supporting surface of the shoe element (3) guiding the shell of the roll in the nip contact varies in the machine direction and the shoe element is positionable in the machine direction to adjust the nip width and/or length.Type: GrantFiled: January 4, 2002Date of Patent: April 15, 2008Assignee: Biohit OyjInventors: Osmo Suovaniemi, Matti Härkönen, Tapani Tiusanen, Pentti Sipponen
-
Patent number: 7344852Abstract: Provided are crystals relating to DPPIV and its various uses.Type: GrantFiled: September 9, 2003Date of Patent: March 18, 2008Assignee: Takeda San Diego, Inc.Inventors: Kathleen Aertgeerts, Ciaran N. Cronin, David J. Hosfield, Mark W. Knuth, Duncan E. McRee, Sridhar Prasad, Bi Ching Sang, Robert J. Skene, Robert A. Wijnands, Sheng Ye
-
Patent number: 7264800Abstract: Improvements in methods of treating cancer with weakly basic anti-cancer compounds are provided. In one aspect, the invention provides an improvement in a method of treating cancer cells whose extracellular environment contains 1–8 mM urea, by exposing the cells to a weakly basic anti-cancer compound which is effective in inhibiting the growth of the cells. The improvement includes (a) exposing the cells to a urease enzyme composition and, (b) by step (a), reducing the amount of anti-cancer compound required to produce a given extent of inhibition in the growth of the cells when the cells are exposed to the anti-cancer agent. Methods of potentiating the specific therapeutic activity of a weakly basic anti-cancer compound in the treatment of a given mammalian cancer which is responsive to the compound are provided as are pharmaceutical compositions for use in intravenous administration to a subject are also provided.Type: GrantFiled: January 27, 2005Date of Patent: September 4, 2007Assignee: Helix BioPharma CorporationInventors: Donald Segal, Jerry McElroy, Heman Chao, Wah Y. Wong, John Docherty, Jodi Dickstein
-
Patent number: 7211250Abstract: A pharmaceutical composition and method for use in inhibiting growth of cancer cells in a mammalian subject are disclosed. The composition includes a urease enzyme, and associated therewith, a chemical entity effective to enhance the delivery of the enzyme to cancer cells, when the composition is administered to the subject. Also disclosed are a method of enhancing the effectiveness of weakly basic anti-tumor compounds, a method assessing the presence, size or condition a solid tumor in a subject, and a gene therapy composition for treating a cancer in a subject.Type: GrantFiled: July 16, 2003Date of Patent: May 1, 2007Assignee: Helix Biopharma CorporationInventors: Don Segal, Jerry McElroy, Heman Chao, Wah Wong, John Docherty, Jodi Dickstein
-
Patent number: 7179609Abstract: A screening method for gastritis is provided. The method involves the serological measurement of at least two of the following analytes: H,K-ATPase antibodies, Helicobacter pylori antibodies and the concentration of pepsinogen I; and the evaluation of the results in comparison with results from normal individuals. The evaluation scheme provides an initial, non-invasive identification of individuals with various forms of gastritis.Type: GrantFiled: October 4, 2000Date of Patent: February 20, 2007Assignee: Atrophus ABInventors: Sven Mårdh, Erik Mårdh
-
Patent number: 7132236Abstract: The invention provides a composition, kit and method for hybridizing a probe and target at a temperature lower than their standard hybridization temperature. The chemical component added to the composition has a formula R(NH2)C?O, where R is amino or alkyl. A method for use of the chemical component and composition is also disclosed.Type: GrantFiled: October 25, 2001Date of Patent: November 7, 2006Assignee: Agilent Technologies, Inc.Inventors: Theodore R. Sana, Paul K. Wolber, Clotilde S. Perbost
-
Patent number: 7125681Abstract: The present invention provides methods and diagnostic kits for the detection of disease-specific antibodies in urine containing sample. The present invention is also directed toward methods for determining that a patient suffers from a disorder characterized by aberrant expression of a naturally occurring gene. Methods for monitoring the status of a disorder in a patient characterized by aberrant expression of a naturally occurring gene are also provided.Type: GrantFiled: June 21, 2002Date of Patent: October 24, 2006Assignee: Ludwig Institute for Cancer ResearchInventors: Alexander Knuth, Elke Jäger, Dirk Jäger
-
Patent number: 7087398Abstract: A system and method for detecting bacterial infections in the gastrointestinal tract is disclosed. In one embodiment, the system includes a first composition separated from a second composition. The first composition contains urea in powdered form. The second composition, on the other hand, contains an indicator. A biopsy of a gastric sample is first contacted with the first composition and then placed in the second composition. The second composition indicates the presence of an enzyme that, in turn, indicates the presence of bacteria. In an alternative embodiment of the present invention, a biopsy of a gastric sample is contacted with a single composition. The composition contains urea in a powdered form combined with a dry indicator. Besides urea and a dry indicator, the composition can also contain an anti-caking agent.Type: GrantFiled: October 15, 2001Date of Patent: August 8, 2006Inventors: Barry J. Marshall, Aruni H. W. Mendis, Simon Chairman
-
Patent number: 7022494Abstract: The invention relates generally to the field of potassium ion detection. In particular, the invention provides methods and kits for assaying for potassium ions in a sample, using, a potassium-dependent urea amidolyase (UAL).Type: GrantFiled: September 19, 2003Date of Patent: April 4, 2006Assignee: General AtomicsInventor: Chong-Sheng Yuan
-
Patent number: 7008777Abstract: A system and method for detecting bacterial infections in the gastrointestinal tract is disclosed. In one embodiment, the system includes a first composition separated from a second composition. The first composition contains urea in powdered form. The second composition, on the other hand, contains an indicator. A biopsy of a gastric sample is first contacted with the first composition and then placed in the second composition. The second composition indicates the presence of an enzyme that, in turn, indicates the presence of bacteria. In an alternative embodiment of the present invention, a biopsy of a gastric sample is contacted with a single composition. The composition contains urea in a powdered form combined with a dry indicator. Besides urea and a dry indicator, the composition can also contain an anti-caking agent.Type: GrantFiled: October 15, 2001Date of Patent: March 7, 2006Inventors: Barry J. Marshall, Aruni H. W. Mendis, Simon Chairman
-
Patent number: 6998250Abstract: A system and method for detecting bacterial infections in the gastrointestinal tract is disclosed. The system includes a carrier having a first well and a second well. A first composition is disposed in the first well and contains urea in powdered form. A second composition is disposed in a second well and contains an indicator. A biopsy of a gastric sample is manipulated with a specimen-handling tool and is first contacted with the first composition and then placed in the second composition. The second composition indicates the presence of an enzyme, which, in turn, indicates the presence of bacteria.Type: GrantFiled: October 15, 2001Date of Patent: February 14, 2006Inventors: Donald J. McMichael, Kristy Peterson, Barry J. Marshall, Aruni H. W. Mendis, Simon Chairman
-
Patent number: 6921647Abstract: A secretion-monitoring article for identifying a secreted biological fluid having a body with an absorbent material and least one pH determining member and a reagent associated with the absorbent material is disclosed. The article can be embodied as a swab, gauze, panty shield, hygienic napkin, diaper or interlabial absorbent structure and can be used to indicate the presence of amniotic fluid, or secretions associated with bacterial, parasite, fungal, or yeast infections without giving a false positive result upon exposure to urine. The present invention also teaches a pH indicator mixture and method of attaching the indicator to a substrate for use alone or integrated in an absorbent body and further teaches a method for monitoring the health condition of a person using the secretion-monitoring article.Type: GrantFiled: November 1, 2002Date of Patent: July 26, 2005Assignee: Common Sense Ltd.Inventors: Amnon Kritzman, Nitsa G. Nachshon, Bechar Yael
-
Patent number: 6872517Abstract: The present invention involves the early diagnosis of cancerous or precancerous conditions in the gastrointestinal tract by detection of a backleak of signature proteins or carbohydrates in a biological sample obtained from the gastrointestinal tract.Type: GrantFiled: May 10, 2001Date of Patent: March 29, 2005Assignee: Lankenau Institute for Medical ResearchInventors: James M. Mullin, James Thornton
-
Patent number: 6806057Abstract: Many of the effects of nitric oxide are mediated by the direct modification of cysteine residues resulting in an adduct called a nitrosothiol. A method to detect proteins which contain nitrosothiols involves several steps. Nitrosylated cysteines are converted to tagged cysteines. Tagged proteins can then be detected, for example, by immunoblotting and/or can be purified by affinity chromatography. The method is applicable to the detection of S-nitrosylated proteins in cell lysates following in vitro S-nitrosylation, as well as to the detection of endogenous S-nitrosothiols in selected protein substrates.Type: GrantFiled: October 29, 2001Date of Patent: October 19, 2004Assignee: The Johns Hopkins UniversityInventors: Solomon H. Snyder, Samie R. Jaffrey, Christopher D. Ferris, Hediye Erdjument-Bromage, Paul Tempst
-
Patent number: 6753159Abstract: The invention provides an enzyme-based device and process for manufacture of the device in a shelf-stable form. The device consists of a dry phase test strip useful in detecting the presence and concentration of uric acid in a liquid sample (such as urine) and has a stabilized uricase-containing working solution impregnated therein. Methods for manufacturing the device to maintain the stability of the working solution, especially the enzyme components therof, are also described. A method for making the uric acid measurement in one step is also provided, wherein the one step to be performed consists of applying the liquid sample to the test strip of the device.Type: GrantFiled: November 8, 2001Date of Patent: June 22, 2004Inventor: Jin Po Lee
-
Patent number: 6733984Abstract: A sensor is provided that is useful for assaying a component of a biological fluid such as blood, urine or milk, and comprises a chamber having an inlet, a liquid containing portion and a vapor containing portion. The liquid and vapor containing portions are in fluid communication. A pressure monitor is in communication with the vapor containing portion and measures pressure change within the vapor containing portion, such as carbon dioxide partial pressure changes which are related to concentration of urea in blood, urine or milk when the enzyme is urease. A method of analyzing a component such as urea in a biological fluid is also provided. Where the biological fluid is dairy milk, milk urea nitrogen to a prediction error of about +/−1 mg/dl may be repeatedly measured in the physiological range of from about 6 to 24 mg/dl.Type: GrantFiled: April 19, 2001Date of Patent: May 11, 2004Assignee: The Regents of the University of CaliforniaInventors: Michael J. Delwiche, Daniel M. Jenkins, Edward J. Depeters, Robert H. Bondurant
-
Publication number: 20040082022Abstract: An artificial plasma-like substance having at least one water soluble polysaccharide oncotic agent selected from the group consisting of high molecular weight hydroxyethyl starch, low molecular weight hydroxyethyl starch, dextran 40 and dextran 70, which is buffered by lactate and has a pre-administration pH of between 4 and 6.5 is disclosed. In one embodiment, the artificial plasma-like solution may have at least two water soluble polysaccharide oncotic agents one of which is eliminated from the circulation slowly and the other of which is eliminated from the circulation quickly. Supplementation of the plasma-like solution with certain ions is described. A system for administration of the plasma-like solution to a subject wherein the system comprises a first and second solution each having particular buffers is described. Methods for the administration of the plasma-like solution are also disclosed.Type: ApplicationFiled: August 13, 2003Publication date: April 29, 2004Inventors: Paul E. Segall, Hal Sternberg, Harold D. Waitz, Judith M. Segall
-
Patent number: 6677129Abstract: A method for oral sampling and rapid, specific detection of the urease activity associated with H. pylori infection in humans without the need for sample incubation. The method involves the steps of gargling, or gargling and rinsing the mouth with a measured volume of sampling liquid with known characteristics; retrieving an oral liquid sample 10 into a collection container 12; acidifying the oral liquid sample; and contacting the oral liquid sample within the collection container with a urease detecting pad 14 containing urease substrate for detection of urease activity present in the oral liquid sample. The urease detecting pad can contain pH indicator for visual identification of color change associated with presence of urease activity in the oral liquid sample. The method provides for sampling of both the pharynx and mouth of the human, either separately or combined for diagnosis.Type: GrantFiled: January 3, 2000Date of Patent: January 13, 2004Inventor: Richard S. Blume
-
Patent number: 6649360Abstract: A testing apparatus for detecting urease in a gastric material taken from a human or lower animal subject is disclosed, the apparatus comprising a dry indicating composition responsive to urease, a backing sheet supporting the dry indicating composition, and a cover sheet sealingly adhered about its periphery to the backing sheet to enclose the dry indicating composition. At least one of the backing sheet or cover sheet has a transparent portion in alignment with the dry indicating composition, and wherein the cover sheet may be peeled from the backing sheet and resealed.Type: GrantFiled: October 2, 2001Date of Patent: November 18, 2003Inventors: Thomas Julius Borody, Nicolas Peter Shortis
-
Patent number: 6642016Abstract: A biosensor comprises a unit, comprising a substrate and an enzyme, which when brought into contact with the substrate is adapted to affect the substrate so that its conductivity changes as a function of time and temperature, and an electric circuit. The unit is included as a component in said electric circuit and the electric circuit is activable by applying an electric field and/or a magnetic field over the same to generate a measurable signal which is dependent on the total resistance of the circuit. The invention also relates to the use of a biosensor, a label with such a biosensor and a method of indicating the status of a product with such a biosensor.Type: GrantFiled: March 27, 2002Date of Patent: November 4, 2003Assignee: Bioett ABInventors: Johan Sjöholm, Per-Olof Erlandsson
-
Patent number: 6627394Abstract: An indicator system including two pH sensitive indicators and a reagent is disclosed. The indicator system can be integrated into a number of products such as sanitary napkins or panty shields and thus can indicate the presence of amniotic fluid or secretions associated with vaginosis without giving a false positive result upon exposure to urine.Type: GrantFiled: July 19, 2001Date of Patent: September 30, 2003Assignee: Common Sense Ltd.Inventors: Amnon Kritzman, Nitsa Galili Nachshon, Yael Behar
-
Publication number: 20030166293Abstract: A secretion-monitoring article for identifying a secreted biological fluid having a body with an absorbent material and least one pH determining member and a reagent associated with the absorbent material is disclosed. The article can be embodied as a swab, gauze, panty shield, hygienic napkin, diaper or interlabial absorbent structure and can be used to indicate the presence of amniotic fluid, or secretions associated with bacterial, parasite, fungal, or yeast infections without giving a false positive result upon exposure to urine. The present invention also teaches a pH indicator mixture and method of attaching the indicator to a substrate for use alone or integrated in an absorbent body and further teaches a method for monitoring the health condition of a person using the secretion-monitoring article.Type: ApplicationFiled: November 1, 2002Publication date: September 4, 2003Applicant: COMMON SENSE LTD.Inventors: Amnon Kritzman, Nitsa G. Nachshon, Bechar Yael
-
Publication number: 20030082661Abstract: A system and method for detecting bacterial infections in the gastrointestinal tract is disclosed. The system includes a carrier having a first well and a second well. A first composition is disposed in the first well and contains urea in powdered form. A second composition is disposed in a second well and contains an indicator. A biopsy of a gastric sample is manipulated with a specimen-handling tool and is first contacted with the first composition and then placed in the second composition. The second composition indicates the presence of an enzyme, which, in turn, indicates the presence of bacteria.Type: ApplicationFiled: October 15, 2001Publication date: May 1, 2003Inventors: Donald J. McMichael, Kristy Peterson, Barry J. Marshall, Aruni H. W. Mendis, Simon Chairman
-
Publication number: 20030077680Abstract: A system and method for detecting bacterial infections in the gastrointestinal tract is disclosed. In one embodiment, the system includes a first composition separated from a second composition. The first composition contains urea in powdered form. The second composition, on the other hand, contains an indicator. A biopsy of a gastric sample is first contacted with the first composition and then placed in the second composition. The second composition indicates the presence of an enzyme that, in turn, indicates the presence of bacteria. In an alternative embodiment of the present invention, a biopsy of a gastric sample is contacted with a single composition. The composition contains urea in a powdered form combined with a dry indicator. Besides urea and a dry indicator, the composition can also contain an anti-caking agent.Type: ApplicationFiled: October 15, 2001Publication date: April 24, 2003Applicant: Kimberly-Clark Worldwide, Inc.Inventors: Barry J. Marshall, Aruni H.W. Mendis, Simon Chairman
-
Patent number: 6548309Abstract: In qualitative or quantitative assays which employ a test device comprising a test strip pretreated for detection of a specified target analyte dissolved in a liquid medium, the presence of solid, semisolid and/or colloidal materials in the liquid medium may interfere with the assay results. The present invention involves collecting the sample from a flowing or quiescent pool of liquid also containing solid, semisolid or colloidal material with a swab comprised of a handle and a mass of fibrous material or foamed, open cell material which, when immersed in and thoroughly wetted by the liquid, entraps solid, semisolid and/or colloidal material and delivers only the liquid to the sample receiving zone of the test strip.Type: GrantFiled: March 19, 1998Date of Patent: April 15, 2003Assignee: Binax, Inc.Inventors: Norman James Moore, Vincent Anthony Sy
-
Patent number: 6521416Abstract: The present invention provides a method for predicting the likely timing of the onset of menopause for a perimenopausal female subject by determining the amount of hLH&bgr;cf in a sample from the subject comprising the steps of: (a) contacting a sample from the subject with an antibody which specifically binds to hLH&bgr;cf without substantially cross-reacting with hLH, hLH&bgr; or hLH&bgr;cf, under conditions permitting formation of a complex between the antibody and hLH&bgr;cf; (b) measuring the amount of complex formed, so as to thereby determine the amount of hLH&bgr;cf in the sample; and (c) comprising the amount of hLH&bgr;cf in the subject's sample determined in step (b) with either (i) the amount determined for known postmenopausal female subject or (ii) the amount determined for a sample from a known premenopausal female subject, wherein an amount of hLH&bgr;cf in the sample similar to the amount of hLH&bgr;cf in the known postmenopausal sample indicates temporal proximity to the onset of menopaType: GrantFiled: August 1, 2000Date of Patent: February 18, 2003Assignee: The Trustees of Columbia University in the City of New YorkInventors: Steven Birken, Yacov Maydelman, Galina I. Kovalevskaya, John F. O'Connor
-
Publication number: 20030017605Abstract: An indicator system including two pH sensitive indicators and a reagent is disclosed. The indicator system can be integrated into a number of products such as sanitary napkins or panty shields and thus can indicate the presence of amniotic fluid or secretions associated with vaginosis without giving a false positive result upon exposure to urine.Type: ApplicationFiled: July 19, 2001Publication date: January 23, 2003Applicant: COMMON SENSE LTD.Inventors: Amnon Kritzman, Nitsa Galili Nachshon, Yael Behar
-
Patent number: 6416968Abstract: This invention relates to methods of screening molecules capable of inhibiting the survival of Helicobacter pylori in vivo by specifically inhibiting the activity of UreI, to the molecules identified by these methods, and to the use of these molecules to treat or prevent H. pylori infection.Type: GrantFiled: August 23, 2000Date of Patent: July 9, 2002Assignee: Institut PasteurInventors: Hilde De Reuse, Stéphane Skouloubris, Valérie Cussac, Agnès Labigne
-
Patent number: 6403099Abstract: The present invention provides conjugate compounds comprising at least one heat shock protein or portion thereof including at least one immunostimulatory domain and at least one capsular oligosaccharide or polysaccharide of a pathogenic bacteria. The compound comprises oligosaccharides of the Meningococci C (MenC) group and a heat shock protein selected from M. bovis BCG GroE1-type 65 kDa hsp (hspR65), recombinant M. tuberculosis DnaK-type 70 kDa hsp (hspR70) and a heat shock protein from H. pylori. The invention also provides processes for producing conjugate compounds, pharmaceutical compositions comprising conjugate compounds, therapeutic compositions comprising conjugate compounds, and methods of inducing an immune response.Type: GrantFiled: November 1, 1994Date of Patent: June 11, 2002Assignee: Chiron S.p.A.Inventors: Rino Rappuoli, Paolo Costantino, Stefano Viti, Francesco Norelli
-
Patent number: 6380380Abstract: Kits and methods for measuring enzyme activities and metabolites using NAD analogs and NADP analogs are disclosed. The analogs can be used as replacements for NAD and NADP cofactors in analytical procedures. Preferred aspects of the invention include kits containing the NAD analogs and NADP analogs for use in the measurement of ethanol, lactic acid, 3-hydroxybutyric acid, glucose, glycerol, triglycerides, alpha-glycerophosphate, bile acids, creatine kinase activity, glucose-6-phosphate dehydrogenase activity and lactic acid dehydrogenase activity in analytical samples.Type: GrantFiled: December 30, 1999Date of Patent: April 30, 2002Assignee: Specialty Assays, Inc.Inventor: Richard A. Kaufman
-
Patent number: 6379910Abstract: One end of a thin-tube type solid phase in which a receptor specific for a material or an organism to be measured which can induce a pH-change of substrate solution is immobilized is soaked in a sample solution and then taken out therefrom. The one end of the thin-tube type solid phase is disposed in a measurement cell and a sensing portion of a pH electrode disposed in the measurement cell is in the vicinity of the one end of the thin-tube type solid phase. The measurement cell and the thin-tube type solid phase are filled with a substrate solution so that a reaction takes place. Thereafter, the substrate solution in the thin-tube type solid phase is moved to the sensing portion by a solution feed pump. The output of the pH electrode at this timing is detected.Type: GrantFiled: June 4, 1998Date of Patent: April 30, 2002Assignee: Nihon Kohden CorporationInventors: Michihiro Nakamura, Harutoshi Terasawa, Hiroyuki Okada, Hidenori Yukawa, Hidehiro Hosaka
-
Patent number: 6376197Abstract: Interstitial cystitis (IC) is a chronic bladder disease for which the exact etiology is unknown and for which there is no reliably effective treatment. However, it is known that the bladder epithelium is often abnormal in IC. We discovered that normal, adult, human bladder epithelial cells are inhibited from proliferating by an anti-proliferative factor (APF) present in IC urine specimens. Inhibited proliferation may cause epithelial abnormalities characteristic of IC such as ulcerations and multiple tears in the bladder epithelium. We further discovered that levels of heparin binding—epidermal growth factor-like growth factor (HB-EGF), a factor known be important for epithelial cell proliferation and wound healing in other tissues, are abnormally low in the urine of patients suffering from IC as compared to asymptomatic controls or patients with acute bacterial cystitis. The invention herein is directed to the use of urine levels of HB-EGF as a diagnostic marker for IC.Type: GrantFiled: May 22, 2000Date of Patent: April 23, 2002Assignee: University of Maryland, BaltimoreInventors: Susan K. Keay, John W. Warren, Michael K. Hise
-
Publication number: 20020012957Abstract: Aqueous solutions comprising a polysaccharide oncotic agent, a physiologically compatible buffer, a simple hexose sugar, dissolved chloride salts of calcium, sodium and magnesium, and a dissolved organic salt of sodium are disclosed. The solutions are effective substitutes for blood and may be used to preserve the biological integrity of the organs of a mammalian donor organism as shown by superior anatomical integrity of cryopreserved organs and tissues of subjects perfused with the solution. The solutions may be used for maintaining a partially or substantially completely exsanguinated subject at normal temperatures and at temperatures substantially below those normally maintained by a mammal and may be used in conjunction with hypobaric environments to maintain such partially or completed exsanguinated subjects alive without infusing blood back into the subject.Type: ApplicationFiled: July 18, 1997Publication date: January 31, 2002Inventors: PAUL E. SEGALL, HAL STERNBERG, HAROLD D. WAITZ, JUDITH M. SEGALL
-
Publication number: 20020009783Abstract: Aqueous solutions comprising a polysaccharide oncotic agent, a physiologically compatible buffer, a simple hexose sugar, dissolved chloride salts of calcium, sodium and magnesium, and a dissolved organic salt of sodium are disclosed. The solutions are effective substitutes for blood and may be used to preserve the biological integrity of the organs of a mammalian donor organism as shown by superior anatomical integrity of cryopreserved organs and tissues of subjects perfused with the solution. The solutions may be used for maintaining a partially or substantially completely exsanguinated subject at normal temperatures and at temperatures substantially below those normally maintained by a mammal and may be used in conjunction with hypobaric environments to maintain such partially or completed exsanguinated subjects alive without infusing blood back into the subject.Type: ApplicationFiled: March 31, 1998Publication date: January 24, 2002Inventors: PAUL E. SEGALL, HAL STERNBERG, HAROLD D. WAITZ, JUDITH M. SEGALL
-
Publication number: 20010051109Abstract: A biosensing system and method are disclosed for the quantitative determination of the concentration of particular analyte ions in biological sera in the presence of interfering ion species and, more particularly, to the quantitative determination of the concentration of analytes that are produced by biologically active materials including enzyme catalyzed reactions and are indicative of the presence of reactant species of interest in blood. The invention further deals with interfering ion species in a manner that eliminates the need for additional sensors or separate baseline sensors. The invention is exemplified by embodiments for the determination of the concentration of blood urea and creatinine using an ion transport related time delay potentiometric determination technique.Type: ApplicationFiled: September 18, 1998Publication date: December 13, 2001Inventors: CARTER R. ANDERSON, KIM ELAYNE PAULSEN
-
Patent number: RE38088Abstract: A process for the determination of H. Pylori in a fecal specimen comprising (a) dispersing a fecal specimen suspected of carrying H. pylori in a sample diluent; (b) contacting the fecal specimen in the diluent with a first polyclonal antibody for H. pylori antigen to form a complex of the antibody and the antigen; (c) separating said specimen and said complex; (d) exposing the complex to a second polyclonal antibody for said antigen and a portion of the antibody reacting with said complex, one of said first and second antibody being bound to a solid carrier and the other being labeled with a detecting agent; and (e) determining the amount of the labeled antibody and in turn determining the presence of H. pylori antigen in said fecal specimen.Type: GrantFiled: February 8, 2000Date of Patent: April 22, 2003Assignee: Meridian Bioscience, Inc.Inventors: Christopher Vance Larka, Ching Sui Arthur Yi, Kenneth James Kozak